US EditionThe potential of typhoid conjugate vaccines to reduce antimicrobial use in Pakistan - Take on Typhoid
Summary by Take on Typhoid
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
The potential of typhoid conjugate vaccines to reduce antimicrobial use in Pakistan - Take on Typhoid
Drug-resistant typhoid is a major public health challenge in Pakistan, where an estimated 25 percent of cases are extensively drug-resistant (XDR). In Pakistan’s Sindh and Punjab provinces, 65% and 44% of blood culture-confirmed typhoid cases are XDR, respectively. XDR Salmonella Typhi (S. Typhi) organisms are resistant to five different classes of antimicrobials, leaving only two effective licensed treatment options. Resistance to these two tre…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
